
  
    
      
        Introduction_NNP
        Squamous_NNP cell_NN carcinoma_NN of_IN the_DT tongue_NN is_VBZ a_DT common_JJ
        malignancy_NN treated_VBN by_IN surgeons_NNS ._. Incidence_NNP of_IN tongue_NN cancer_NN
        in_IN India_NNP is_VBZ second_JJ highest_JJS in_IN the_DT world_NN ._. Among_IN males_NNS the_DT
        age_NN adjusted_VBD incidence_NN rate_NN is_VBZ as_RB high_JJ as_IN 14_CD /_NN 100_CD ,_, 000_CD
        per_IN /_NN year_NN in_IN Ahmedabad_NNP while_IN among_IN females_NNS it_PRP is_VBZ 7_CD ._. 4_CD /_NN
        100_CD ,_, 000_CD in_IN Mumbai_NNP [_NN 1_CD ]_NN ._. In_IN Trivandrum_NNP the_DT incidence_NN of_IN
        tongue_NN cancer_NN is_VBZ 5_CD ._. 2_CD /_NN 100_CD ,_, 000_CD among_IN males_NNS and_CC 2_CD ._. 4_CD /_NN 100_CD ,_, 000_CD
        among_IN females_NNS [_NN 2_CD ]_NN ._.
        Tongue_NNP is_VBZ a_DT complex_JJ anatomical_JJ site_NN and_CC its_PRP$ form_NN and_CC
        function_NN are_VBP crucial_JJ for_IN efficient_JJ swallowing_VBG ,_, speech_NN and_CC
        appreciation_NN of_IN taste_NN ._. In_IN past_JJ different_JJ methods_NNS of_IN
        treatment_NN have_VBP been_VBN employed_VBN but_CC tongue_NN has_VBZ remained_VBN a_DT
        difficult_JJ area_NN to_TO assess_VB and_CC treat_VB ._. The_DT survival_NN in_IN
        carcinoma_NN of_IN the_DT tongue_NN is_VBZ poor_JJ compared_VBN to_TO other_JJ subsites_NNS
        in_IN oral_JJ cavity_NN ._.
        The_DT distribution_NN of_IN cervical_JJ lymph_NN node_NN metastasis_NNS from_IN
        squamous_JJ cell_NN carcinoma_NN at_IN different_JJ subsites_NNS in_IN the_DT oral_JJ
        cavity_NN has_VBZ been_VBN described_VBN before_IN [_NN 3_CD 4_CD 5_CD ]_NN ._. However_RB ,_, there_EX
        are_VBP very_RB few_JJ studies_NNS from_IN India_NNP ,_, where_WRB the_DT incidence_NN of_IN
        tongue_NN cancer_NN is_VBZ high_JJ ._. The_DT distribution_NN of_IN metastases_NNS
        suggests_VBZ skip_VB lesions_NNS and_CC peppering_VBG [_NN 3_CD 5_CD 6_CD ]_NN ._. Predicting_VBG
        the_DT lymphatic_JJ spread_NN from_IN cancer_NN of_IN the_DT oral_JJ tongue_NN can_MD
        help_VB in_IN choosing_VBG the_DT appropriate_JJ surgical_JJ procedure_NN and_CC may_MD
        also_RB help_VB in_IN predicting_VBG the_DT outcome_NN ._. The_DT purpose_NN of_IN the_DT
        present_JJ study_NN was_VBD to_TO assess_VB the_DT pattern_NN of_IN cervical_JJ node_NN
        metastasis_NNS from_IN carcinoma_NN of_IN the_DT oral_JJ tongue_NN and_CC to_TO
        evaluate_VB the_DT impact_NN of_IN tumour_NN status_NN on_IN survival_NN ._.
      
      
        Patients_NNS and_CC Methods_NNP
        A_DT retrospective_NN analysis_NN of_IN 75_CD patients_NNS undergoing_VBG
        primary_JJ surgical_JJ resection_NN for_IN squamous_JJ cell_NN carcinoma_NN of_IN
        oral_JJ tongue_NN between_IN January_NNP 1997_CD and_CC December_NNP 1998_CD ,_, in_IN a_DT
        single_JJ surgical_JJ unit_NN ,_, was_VBD carried_VBN out_IN to_TO evaluate_VB the_DT
        pattern_NN of_IN nodal_NN metastasis_NNS and_CC survival_NN ._. The_DT variables_NNS
        like_IN age_NN ,_, sex_NN ,_, tumour_NN size_NN ,_, grade_NN ,_, clinical_JJ TNM_NNP ,_,
        pathological_JJ TNM_NNP and_CC histopathological_JJ levels_NNS of_IN
        involvement_NN were_VBD extracted_VBN from_IN case_NN records_NNS ._. All_DT the_DT
        patients_NNS underwent_VBD evaluation_NN under_IN general_JJ anaesthesia_NN
        before_IN the_DT surgery_NN and_CC clinical_JJ TNM_NNP was_VBD modified_VBN if_IN
        indicated_VBD ._. The_DT types_NNS of_IN surgical_JJ procedures_NNS performed_VBN are_VBP
        detailed_JJ in_IN table_NN 1_CD ._. Adjuvant_NNP radiotherapy_NN (_( 45_CD Gy_NNP /_NN 15_CD
        fraction_NN )_) was_VBD given_VBN if_IN the_DT primary_JJ tumour_NN was_VBD greater_JJR than_IN
        2_CD cm_NN ,_, had_VBD close_VB margins_NNS or_CC nodal_NN involvement_NN was_VBD present_JJ or_CC
        there_EX was_VBD extranodal_NN involvement_NN ._. Minimum_NNP duration_NN of_IN
        follow-up_JJ was_VBD two_CD years_NNS following_VBG surgery_NN ._. Survival_NNP
        analysis_NN was_VBD carried_VBN by_IN Kaplan-_NNP Meier_NNP method_NN and_CC the_DT curves_NNS
        were_VBD compared_VBN using_VBG log_NN rank_NN test_NN ._. Multivariate_NNP analysis_NN
        was_VBD carried_VBN out_IN using_VBG Cox_NNP proportional_JJ hazard_NN model_NN ._.
      
      
        Results_NNS
        Age_NNP of_IN the_DT patients_NNS ranged_VBD from_IN 22_CD to_TO 75_CD years_NNS with_IN a_DT
        mean_JJ age_NN of_IN 52_CD ._. 6_CD years_NNS ._. The_DT male_JJ ,_, female_JJ ratio_NN was_VBD 1_CD ._. 5_CD :_: 1_CD
        (_( Table_NNP 2_LS )_) ._. All_DT the_DT patients_NNS had_VBD undergone_VBN primary_JJ surgical_JJ
        resection_NN ._.
        At_IN presentation_NN ,_, 44_CD %_NN of_IN patients_NNS had_VBD T_NN 
        2_CD tumour_NN followed_VBN by_IN T_NN 
        3_CD in_IN 20_CD %_NN (_( Table_NNP 2_LS )_) ._. Clinically_NNP 34_CD
        patients_NNS were_VBD found_VBN to_TO be_VB neck_NN node_NN positive_NN of_IN which_WDT 26_CD
        (_( 34_CD ._. 7_CD %_NN )_) were_VBD cN_NN 
        1_CD ,_, 6_CD (_( 8_CD %_NN )_) were_VBD cN_NN 
        2_CD b_SYM and_CC 2_CD (_( 2_CD ._. 7_CD %_NN )_) were_VBD cN_NN 
        2_CD c_SYM ._. Histologically_NNP 33_CD cases_NNS were_VBD found_VBN
        to_TO have_VB positive_JJ neck_NN nodes_NNS ,_, of_IN which_WDT majority_NN (_( 16_CD ;_: 21_CD ._. 3_LS %_NN )_)
        were_VBD pN_NN 
        2_CD b_SYM ._. The_DT T_NN and_CC N_NNP stage_NN distribution_NN is_VBZ
        detailed_VBN in_IN table_NN 2_CD ._. Cervical_NNP lymph_NN node_NN metastasis_NNS was_VBD
        present_JJ in_IN 47_CD ._. 1_LS %_NN of_IN T_NN 
        1_CD tumours_NNS ,_, 24_CD ._. 13_CD %_NN of_IN T_NN 
        2_CD tumours_NNS ,_, 63_CD ._. 6_CD %_NN of_IN T_NN 
        3_CD tumours_NNS and_CC 61_CD ._. 1_LS %_NN of_IN T_NN 
        4_CD tumours_NNS (_( Table_NNP 3_LS )_) ._. Histologically_NNP 18_CD
        cases_NNS were_VBD true_JJ positive_NN for_IN nodal_NN metastasis_NNS while_IN 26_CD
        cases_NNS were_VBD true_JJ negative_JJ giving_NN a_DT sensitivity_NN of_IN 54_CD ._. 5_LS %_NN and_CC
        specificity_NN of_IN 61_CD ._. 9_CD %_NN for_IN clinical_JJ examination_NN of_IN the_DT neck_NN
        (_( Table_NNP 4_LS )_) ._. Synchronous_NNP discontinuous_JJ operations_NNS were_VBD
        performed_VBN in_IN all_DT cases_NNS ._. None_NN of_IN the_DT patients_NNS had_VBD a_DT positive_JJ
        resection_NN margin_NN ,_, however_RB the_DT margin_NN was_VBD close_VB (_( 2_CD -_: 5_CD mm_NN )_) in_IN
        11_CD cases_NNS ._. Neck_NNP was_VBD managed_VBN by_IN vein_NN preserving_VBG neck_NN
        dissection_NN in_IN 27_CD cases_NNS (_( 36_CD %_NN )_) and_CC supraomohyoid_NN neck_NN
        dissection_NN in_IN 22_CD cases_NNS (_( 29_CD ._. 3_LS %_NN )_) (_( Table_NNP 1_LS )_) ._. It_PRP was_VBD observed_VBN
        that_IN the_DT nodal_NN involvement_NN in_IN ipsilateral_NN level_NN II_NNP was_VBD
        highest_JJS (_( 63_CD ._. 6_CD %_NN )_) ,_, followed_VBN by_IN the_DT involvement_NN of_IN level_NN I_PRP
        (_( 51_CD ._. 5_LS %_NN )_) ,_, level_NN III_NNP (_( 18_CD ._. 2_LS %_NN )_) and_CC level_NN IV_NNP (_( 15_CD ._. 2_LS %_NN )_) (_( Table_NNP 1_LS )_) ._.
        Table_NNP 2_CD shows_VBZ the_DT distribution_NN of_IN nodes_NNS at_IN different_JJ levels_NNS
        of_IN the_DT neck_NN in_IN varying_VBG combination_NN ._. Skip_NNP metastasis_NNS to_TO
        level_VB III_NNP /_NN III_NNP and_CC IV_NNP occurred_VBD in_IN 5_CD cases_NNS ._. On_IN
        histopathological_JJ examination_NN ,_, only_RB one_CD patient_NN had_VBD
        bilateral_JJ positive_JJ nodes_NNS ._. These_DT nodes_NNS were_VBD located_VBN at_IN level_NN
        I_PRP bilaterally_RB and_CC the_DT patient_NN had_VBD undergone_VBN bilateral_JJ vein_NN
        preserving_VBG neck_NN dissection_NN (_( Table_NNP 1_LS )_) ._. A_DT total_NN of_IN 59_CD
        patients_NNS received_VBD adjuvant_NN radiotherapy_NN ,_, radiotherapy_NN was_VBD
        given_VBN to_TO 32_CD /_NN 34_CD patients_NNS with_IN N_NNP +_NN disease_NN ,_, or_CC extranodal_NN
        spread_VBD ._. Nine_CD patients_NNS with_IN T_NN 1_CD N_NNP 0_CD disease_NN and_CC 5_CD patients_NNS with_IN
        T_NN 2_CD N_NNP 0_CD disease_NN and_CC one_CD patient_NN each_DT with_IN T_NN 1_CD N_NNP 1_CD and_CC T_NN 2_CD N_NNP 1_CD
        disease_NN did_VBD not_RB receive_VB adjuvant_NN radiotherapy_NN ._.
        Over_IN the_DT two-year_JJ follow-up_JJ ,_, 19_CD cases_NNS failed_VBD ,_, the_DT
        failure_NN was_VBD nodal_NN in_IN 8_CD ,_, primary_JJ in_IN 8_CD ,_, and_CC both_DT primary_NN and_CC
        nodal_NN in_IN 3_CD patients_NNS ._. The_DT clinical_JJ TNM_NNP ,_, pathological_JJ TNM_NNP and_CC
        level_NN of_IN positive_JJ node_NN are_VBP illustrated_VBN in_IN additional_JJ table_NN
        1_CD ._. The_DT overall_JJ disease_NN free_JJ survival_NN (_( DFS_NNP )_) was_VBD found_VBN to_TO be_VB
        78_CD ._. 4_LS %_NN at_IN 1_CD -_: year_NN and_CC 68_CD ._. 4_LS %_NN at_IN 2_CD -_: years_NNS (_( Table_NNP 5_LS )_) (_( fig_NN 1_LS )_) ._.
        Patients_NNS with_IN T_NN 
        4_CD tumours_NNS were_VBD found_VBN to_TO have_VB a_DT
        significantly_RB poor_JJ survival_NN ,_, with_IN the_DT disease_NN free_JJ survival_NN
        at_IN the_DT end_NN of_IN 2_CD -_: years_NNS being_VBG 36_CD ._. 6_CD %_NN ._. T_NN 
        1_CD and_CC T_NN 
        2_CD tumours_NNS showed_VBD better_JJR prognosis_NN with_IN
        disease_NN free_JJ survival_NN of_IN 76_CD ._. 2_LS %_NN and_CC 83_CD ._. 5_LS %_NN respectively_RB at_IN
        the_DT end_NN of_IN 2_CD -_: years_NNS (_( Table_NNP 5_LS )_) (_( figure_NN 2_LS )_) ._.
        Histopathological_NNP node_NN negative_JJ cases_NNS had_VBD a_DT DFS_NNP of_IN 79_CD %_NN at_IN
        the_DT end_NN of_IN 2_CD -_: years_NNS whereas_IN pathological_JJ N_NNP 
        1_CD (_( pN_NN 
        1_LS )_) had_VBD survival_NN of_IN 72_CD ._. 7_CD %_NN and_CC pN_NN 
        2_CD of_IN 39_CD ._. 5_LS %_NN (_( P_NN =_SYM 0_CD ._. 03_CD )_) (_( Table_NNP 5_LS )_) (_( figure_NN
        3_LS )_) ._. No_DT other_JJ parameter_NN including_VBG use_NN of_IN adjuvant_NN
        radiotherapy_NN was_VBD found_VBN to_TO have_VB significant_JJ effect_NN on_IN
        disease_NN free_JJ survival_NN ._. On_IN multivariate_NN analysis_NN the_DT tumour_NN
        size_NN and_CC nodal_NN metastasis_NNS were_VBD found_VBN to_TO be_VB significant_JJ
        independent_JJ prognostic_JJ factors_NNS ._. The_DT hazard_NN ratio_NN for_IN
        failure_NN was_VBD 1_CD ._. 0_CD for_IN T_NN 2_CD ,_, 1_CD ._. 7_CD for_IN T_NN 1_CD ,_, 1_CD ._. 72_CD for_IN T_NN 3_CD and_CC 1_CD ._. 84_CD
        for_IN T_NN 4_CD tumours_NNS ._. Similarly_RB hazard_NN ratio_NN for_IN failure_NN in_IN N_NNP 0_CD
        disease_NN was_VBD 1_CD ._. 0_CD ,_, it_PRP was_VBD 9_CD ._. 9_CD in_IN N_NNP 1_CD ,_, 14_CD ._. 9_CD in_IN N_NNP 2_CD and_CC 21_CD ._. 2_LS in_IN
        N_NNP 3_CD disease_NN ._. Sex_NN was_VBD also_RB found_VBN to_TO be_VB an_DT independent_JJ
        prognostic_JJ factor_NN with_IN hazard_NN ratio_NN for_IN males_NNS being_VBG 1_CD ._. 4_CD
        however_RB this_DT difference_NN was_VBD statistically_RB not_RB
        significant_JJ ._.
      
      
        Discussion_NNP
        Squamous_NNP cell_NN carcinoma_NN arising_VBG in_IN oral_JJ tongue_NN is_VBZ
        curable_JJ if_IN assessed_VBN and_CC treated_VBN appropriately_RB ._. Clinically_NNP
        undetectable_JJ nodal_NN metastasis_NNS is_VBZ the_DT commonest_NN cause_NN of_IN
        treatment_NN failure_NN ._. Incidence_NNP of_IN neck_NN metastasis_NNS in_IN oral_JJ SCC_NNP
        is_VBZ reported_VBN to_TO be_VB 34_CD %_NN to_TO 50_CD %_NN [_NN 7_CD 8_CD ]_NN ._. In_IN our_PRP$ series_NN ,_, level_NN

        II_NNP was_VBD found_VBN to_TO be_VB the_DT most_RBS commonly_RB involved_VBN site_NN (_( 63_CD ._. 6_CD %_NN )_)
        and_CC level_NN IV_NNP involvement_NN was_VBD seen_VBN in_IN 15_CD ._. 2_LS %_NN patients_NNS ._.
        Isolated_NNP level_NN IV_NNP involvement_NN in_IN absence_NN of_IN involvement_NN of_IN
        one_CD of_IN the_DT higher_JJR levels_NNS (_( I_NN ,_, II_NNP or_CC III_NNP )_) was_VBD not_RB documented_VBN
        in_IN any_DT patient_NN in_IN the_DT present_JJ study_NN ._. Further_RB ,_, clinically_RB
        node_NN negative_JJ cases_NNS never_RB showed_VBD level_NN IV_NNP involvement_NN ._. Shah_NNP
        et_CC al_NN (_( 1990_CD )_) [_NN 4_CD ]_NN had_VBD documented_VBN similar_JJ results_NNS ._. Hence_RB ,_, a_DT
        supraomohyoid_NN neck_NN dissection_NN is_VBZ justified_JJ when_WRB the_DT neck_NN is_VBZ
        clinically_RB negative_JJ ._. On_IN the_DT contrary_JJ Byers_NNP et_CC al_NN (_( 1997_CD )_) [_NN 3_CD
        ]_NN ,_, found_VBD 16_CD %_NN of_IN patients_NNS with_IN oral_JJ cancer_NN ,_, to_TO have_VB
        metastasis_NNS in_IN level_NN IV_NNP without_IN nodes_NNS in_IN level_NN I_PRP ,_, II_NNP or_CC
        III_NNP ._.
        It_PRP was_VBD seen_VBN that_IN only_RB 35_CD ._. 6_CD %_NN of_IN T_NN 
        1_CD and_CC T_NN 
        2_CD lesions_NNS showed_VBD nodal_NN metastasis_NNS where_WRB
        as_IN 62_CD ._. 3_LS %_NN of_IN the_DT larger_JJR tumours_NNS showed_VBD metastasis_NNS (_( Table_NNP 3_LS )_) ._.
        Previous_JJ studies_NNS [_NN 9_CD 6_CD ]_NN support_NN our_PRP$ finding_VBG that_DT tumour_NN
        size_NN is_VBZ a_DT predictor_NN of_IN lymph_NN node_NN metastasis_NNS though_IN they_PRP
        propose_VBP that_DT tumour_NN thickness_NN is_VBZ a_DT more_RBR reliable_JJ factor_NN ._.
        This_DT is_VBZ further_RBR explained_VBN by_IN DiTroia_NNP (_( 1972_CD )_) [_NN 10_CD ]_NN ,_, who_WP
        points_VBZ to_TO difficulty_NN for_IN the_DT tumour_NN emboli_NN to_TO form_VB in_IN small_JJ
        calibre_NN lymphatics_NNS of_IN the_DT superficial_JJ areas_NNS ,_, compared_VBN with_IN
        wider_RBR lymphatic_JJ of_IN deeper_JJR tissues_NNS ._. However_RB ,_, tumour_NN
        thickness_NN is_VBZ a_DT radiological_JJ or_CC histological_JJ parameter_NN ,_,
        which_WDT cannot_NN be_VB assessed_VBN preoperatively_RB by_IN clinical_JJ
        examination_NN or_CC biopsy_NN ._.
        In_IN our_PRP$ study_NN ,_, sensitivity_NN and_CC specificity_NN of_IN clinical_JJ
        examination_NN was_VBD poor_JJ suggesting_VBG that_IN clinical_JJ examination_NN
        is_VBZ of_IN limited_JJ use_NN in_IN predicting_VBG cervical_JJ nodal_NN metastasis_NNS ._.
        This_DT is_VBZ in_IN accord_NN with_IN previous_JJ studies_NNS [_NN 5_CD 6_CD ]_NN ._. One_CD
        option_NN would_MD be_VB to_TO look_VB for_IN a_DT more_RBR reliable_JJ methods_NNS to_TO
        asses_NNS the_DT neck_NN ._. Sajeeda_NNP et_CC al_NN (_( 2000_CD )_) [_NN 11_CD ]_NN documented_VBN that_DT
        ultrasonography_NN is_VBZ not_RB only_RB useful_JJ in_IN detecting_VBG neck_NN nodes_NNS
        but_CC is_VBZ also_RB useful_JJ in_IN assessing_VBG the_DT nodal_NN characteristic_JJ
        and_CC the_DT degree_NN of_IN vascular_NN invasion_NN ._. Takashima_NNP et_CC al_NN (_( 1997_CD )_)
        [_NN 12_CD ]_NN demonstrated_VBD ultrasound_NN guided_VBD fine_NN needle_NN
        aspiration_NN to_TO have_VB 93_CD ._. 7_CD %_NN diagnostic_JJ accuracy_NN ._. Computed_NNP
        tomographic_JJ (_( CT_NNP )_) scanning_VBG too_RB is_VBZ very_RB useful_JJ for_IN the_DT
        purpose_NN of_IN early_JJ detection_NN of_IN neck_NN metastasis_NNS [_NN 13_CD ]_NN ._.
        Magnetic_JJ resonance_NN imaging_NN (_( MRI_NNP )_) on_IN the_DT other_JJ hand_NN has_VBZ been_VBN
        found_VBN to_TO have_VB little_JJ advantage_NN over_IN clinical_JJ examination_NN as_IN
        the_DT soft_JJ tissue_NN contrast_NN resolution_NN reported_VBN by_IN MRI_NNP is_VBZ
        inadequate_JJ to_TO detect_VB minimal_JJ morphological_JJ changes_NNS in_IN lymph_NN
        nodes_NNS [_NN 14_CD ]_NN ._.
        The_DT technique_NN of_IN sentinel_NN node_NN biopsy_NN is_VBZ gaining_VBG
        popularity_NN ._. Surgery_NNP on_IN the_DT primary_JJ tumour_NN often_RB modifies_VBZ
        lymphatic_JJ drainage_NN ,_, so_RB sentinel_NN node_NN biopsy_NN is_VBZ useful_JJ when_WRB
        primary_JJ tumour_NN and_CC neck_NN are_VBP operated_VBN at_IN the_DT same_JJ time_NN [_NN 15_CD
        ]_NN ._. If_IN the_DT treatment_NN decision_NN has_VBZ to_TO be_VB based_VBN on_IN the_DT
        present_JJ sensitivity_NN and_CC specificity_NN of_IN clinical_JJ
        examination_NN ,_, then_RB a_DT minimum_JJ selective_JJ neck_NN dissection_NN
        should_MD be_VB carried_VBN out_IN for_IN all_DT node_NN negative_JJ necks_NNS where_WRB
        primary_NN is_VBZ being_VBG treated_VBN by_IN surgery_NN as_IN primary_JJ modality_NN ._.
        Studies_NNS have_VBP documented_VBN that_DT ipsilateral_NN level_NN I_PRP ,_, II_NNP and_CC
        III_NNP neck_NN dissection_NN is_VBZ an_DT adequate_JJ diagnostic_JJ procedure_NN for_IN
        staging_NN of_IN the_DT clinically_RB node_NN negative_JJ neck_NN in_IN early_JJ oral_JJ
        tongue_NN cancer_NN [_NN 16_CD 17_CD ]_NN ._. Its_PRP$ diagnostic_JJ role_NN cannot_NN be_VB
        replaced_VBN by_IN preoperative_JJ radiological_JJ screening_NN and_CC
        intraoperative_JJ frozen_VBN section_NN sampling_VBG ._.
        T_NN 
        1_CD and_CC T_NN 
        2_CD tumours_NNS show_VBP a_DT similar_JJ ,_, significantly_RB
        higher_JJR disease_NN free_JJ survival_NN compared_VBN to_TO T_NN 
        3_CD and_CC T_NN 
        4_CD tumours_NNS ,_, even_RB though_IN the_DT number_NN in_IN the_DT
        present_JJ study_NN is_VBZ small_JJ the_DT conclusions_NNS can_MD be_VB drawn_VBN with_IN
        conviction_NN from_IN these_DT results_NNS as_IN shown_VBN in_IN earlier_JJR studies_NNS
        on_IN smaller_JJR sample_NN size_NN [_NN 18_CD ]_NN ._. Brown_NNP et_CC al_NN (_( 1989_CD )_) [_NN 19_CD ]_NN
        too_RB have_VBP shown_VBN similar_JJ results_NNS ._. Nodal_NNP metastases_NNS too_RB
        significantly_RB correlate_VBP with_IN disease_NN free_JJ survival_NN as_RB also_RB
        documented_VBN by_IN Woolgar_NNP et_CC al_NN (_( 1999_CD )_) [_NN 6_CD ]_NN ._. Similar_JJ results_NNS
        were_VBD seen_VBN in_IN the_DT present_JJ study_NN as_IN well_RB ,_, where_WRB tumour_NN size_NN ,_,
        nodal_NN status_NN and_CC surgery_NN as_IN primary_JJ modality_NN were_VBD found_VBN to_TO
        be_VB a_DT significant_JJ predictor_NN of_IN disease_NN free_JJ survival_NN ._.
        In_IN the_DT light_NN of_IN the_DT present_JJ results_NNS showing_VBG a_DT poor_JJ
        sensitivity_NN and_CC specificity_NN of_IN clinical_JJ examination_NN in_IN
        predicting_VBG nodal_NN metastasis_NNS and_CC infrequent_JJ involvement_NN of_IN
        level_NN IV_NNP in_IN the_DT absence_NN of_IN involvement_NN of_IN higher_JJR levels_NNS ,_, we_PRP
        suggest_VBP that_IN a_DT supraomohyoid_NN neck_NN dissection_NN should_MD be_VB
        carried_VBN out_IN in_IN all_DT patients_NNS of_IN the_DT oral_JJ tongue_NN cancer_NN with_IN
        clinically_RB node_NN negative_JJ neck_NN to_TO achieve_VB a_DT better_JJR disease_NN
        free_JJ survival_NN ._.
      
    
  
